Companion animals are growing in importance for Eurovet Animal Health.

This segment already accounts for around 25% of turnover.

We are generating further growth by expanding our position in the therapeutic segments of endocrinology, anaesthetics/analgesia and cardiovascular medicines.

Optimising the profitability of our current STAR products will strongly contribute to this growth. In addition, we are stimulating growth through the careful expansion of our range with newly developed and in-licensed products.